Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 893 entries
Sorted by: Best Match Show Resources per page
Genetic and epigenetic regulation of intestinal fibrosis.

United European gastroenterology journal

Li C, Kuemmerle JF.
PMID: 27536359
United European Gastroenterol J. 2016 Aug;4(4):496-505. doi: 10.1177/2050640616659023. Epub 2016 Jul 14.

Crohn's disease affects those individuals with polygenic risk factors. The identified risk loci indicate that the genetic architecture of Crohn's disease involves both innate and adaptive immunity and the response to the intestinal environment including the microbiome. Genetic risk...

Cite
Li C, Kuemmerle JF. Genetic and epigenetic regulation of intestinal fibrosis. United European Gastroenterol J. 2016;4(4):496-505doi: 10.1177/2050640616659023.
Li, C., & Kuemmerle, J. F. (2016). Genetic and epigenetic regulation of intestinal fibrosis. United European gastroenterology journal, 4(4), 496-505. https://doi.org/10.1177/2050640616659023
Li, Chao, and Kuemmerle, John F. "Genetic and epigenetic regulation of intestinal fibrosis." United European gastroenterology journal vol. 4,4 (2016): 496-505. doi: https://doi.org/10.1177/2050640616659023
Li C, Kuemmerle JF. Genetic and epigenetic regulation of intestinal fibrosis. United European Gastroenterol J. 2016 Aug;4(4):496-505. doi: 10.1177/2050640616659023. Epub 2016 Jul 14. PMID: 27536359; PMCID: PMC4971799.
Copy Download .nbib Format: NLM
Imaging of intestinal fibrosis: current challenges and future methods.

United European gastroenterology journal

Stidham RW, Higgins PD.
PMID: 27536361
United European Gastroenterol J. 2016 Aug;4(4):515-22. doi: 10.1177/2050640616636620. Epub 2016 Mar 02.

Crohn's disease (CD) activity assessments are dominated by inflammatory changes without discrete measurement of the coexisting fibrotic contribution to total bowel damage. Intestinal fibrosis impacts the development of severe structural complications and the overall natural history of CD. Measuring...

Cite
Stidham RW, Higgins PD. Imaging of intestinal fibrosis: current challenges and future methods. United European Gastroenterol J. 2016;4(4):515-22doi: 10.1177/2050640616636620.
Stidham, R. W., & Higgins, P. D. (2016). Imaging of intestinal fibrosis: current challenges and future methods. United European gastroenterology journal, 4(4), 515-22. https://doi.org/10.1177/2050640616636620
Stidham, Ryan W, and Higgins, Peter Dr. "Imaging of intestinal fibrosis: current challenges and future methods." United European gastroenterology journal vol. 4,4 (2016): 515-22. doi: https://doi.org/10.1177/2050640616636620
Stidham RW, Higgins PD. Imaging of intestinal fibrosis: current challenges and future methods. United European Gastroenterol J. 2016 Aug;4(4):515-22. doi: 10.1177/2050640616636620. Epub 2016 Mar 02. PMID: 27536361; PMCID: PMC4971796.
Copy Download .nbib Format: NLM
Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.

United European gastroenterology journal

Schmidt A, Bloechinger M, Weber A, Siveke J, von Delius S, Prinz C, Schmitt W, Schmid RM, Neu B.
PMID: 27536367
United European Gastroenterol J. 2016 Aug;4(4):570-9. doi: 10.1177/2050640615621235. Epub 2016 Feb 03.

BACKGROUND AND STUDY AIMS: Radiofrequency ablation (RFA) is a new endoscopic palliation therapy for malignant biliary obstruction. The aim of this study was to compare the short-term effects of biliary drainage and adverse events of this technique with the...

Cite
Schmidt A, Bloechinger M, Weber A, et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J. 2016;4(4):570-9doi: 10.1177/2050640615621235.
Schmidt, A., Bloechinger, M., Weber, A., Siveke, J., von Delius, S., Prinz, C., Schmitt, W., Schmid, R. M., & Neu, B. (2016). Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European gastroenterology journal, 4(4), 570-9. https://doi.org/10.1177/2050640615621235
Schmidt, A, et al. "Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma." United European gastroenterology journal vol. 4,4 (2016): 570-9. doi: https://doi.org/10.1177/2050640615621235
Schmidt A, Bloechinger M, Weber A, Siveke J, von Delius S, Prinz C, Schmitt W, Schmid RM, Neu B. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J. 2016 Aug;4(4):570-9. doi: 10.1177/2050640615621235. Epub 2016 Feb 03. PMID: 27536367; PMCID: PMC4971790.
Copy Download .nbib Format: NLM
Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas.

United European gastroenterology journal

Robles EP, Maire F, Cros J, Vullierme MP, Rebours V, Sauvanet A, Aubert A, Dokmak S, Lévy P, Ruszniewski P.
PMID: 27536368
United European Gastroenterol J. 2016 Aug;4(4):580-6. doi: 10.1177/2050640615623370. Epub 2016 Jan 06.

OBJECTIVE: To determine accuracy of 2012 International Consensus Guidelines (ICG) predicting malignancy in a surgical cohort of branch-duct intraductal papillary mucinous neoplasms (BD-IPMN).METHODS: This study included all consecutive patients with final pathological diagnosis of pure BD-IPMN resected between 2006...

Cite
Robles EP, Maire F, Cros J, et al. Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. United European Gastroenterol J. 2016;4(4):580-6doi: 10.1177/2050640615623370.
Robles, E. P., Maire, F., Cros, J., Vullierme, M. P., Rebours, V., Sauvanet, A., Aubert, A., Dokmak, S., Lévy, P., & Ruszniewski, P. (2016). Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. United European gastroenterology journal, 4(4), 580-6. https://doi.org/10.1177/2050640615623370
Robles, Enrique Pérez-Cuadrado, et al. "Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas." United European gastroenterology journal vol. 4,4 (2016): 580-6. doi: https://doi.org/10.1177/2050640615623370
Robles EP, Maire F, Cros J, Vullierme MP, Rebours V, Sauvanet A, Aubert A, Dokmak S, Lévy P, Ruszniewski P. Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. United European Gastroenterol J. 2016 Aug;4(4):580-6. doi: 10.1177/2050640615623370. Epub 2016 Jan 06. PMID: 27536368; PMCID: PMC4971792.
Copy Download .nbib Format: NLM
Confocal laser endomicroscopy features of sessile serrated adenomas/polyps.

United European gastroenterology journal

Parikh ND, Gibson J, Nagar A, Ahmed AA, Aslanian HR.
PMID: 27536371
United European Gastroenterol J. 2016 Aug;4(4):599-603. doi: 10.1177/2050640615621819. Epub 2015 Dec 15.

BACKGROUND AND AIMS: Sessile serrated adenomas/polyps (SSA/Ps) are difficult to differentiate from non-neoplastic tissue on white-light endoscopy. Confocal laser endomicroscopy (CLE) provides subcellular imaging and real-time "optical biopsy". The aim of this study was to prospectively describe CLE features...

Cite
Parikh ND, Gibson J, Nagar A, et al. Confocal laser endomicroscopy features of sessile serrated adenomas/polyps. United European Gastroenterol J. 2015;4(4):599-603doi: 10.1177/2050640615621819.
Parikh, N. D., Gibson, J., Nagar, A., Ahmed, A. A., & Aslanian, H. R. (2016). Confocal laser endomicroscopy features of sessile serrated adenomas/polyps. United European gastroenterology journal, 4(4), 599-603. https://doi.org/10.1177/2050640615621819
Parikh, Neil D, et al. "Confocal laser endomicroscopy features of sessile serrated adenomas/polyps." United European gastroenterology journal vol. 4,4 (2016): 599-603. doi: https://doi.org/10.1177/2050640615621819
Parikh ND, Gibson J, Nagar A, Ahmed AA, Aslanian HR. Confocal laser endomicroscopy features of sessile serrated adenomas/polyps. United European Gastroenterol J. 2016 Aug;4(4):599-603. doi: 10.1177/2050640615621819. Epub 2015 Dec 15. PMID: 27536371; PMCID: PMC4971791.
Copy Download .nbib Format: NLM
Endoscopic removal of over-the-scope clips: Clinical experience with a bipolar cutting device.

United European gastroenterology journal

Bauder M, Meier B, Caca K, Schmidt A.
PMID: 28588877
United European Gastroenterol J. 2017 Jun;5(4):479-484. doi: 10.1177/2050640616671846. Epub 2016 Oct 06.

BACKGROUND: Over-the-scope clips (OTSCs) are increasingly used for the closure of perforations/fistulae, hemostasis and endoscopic full-thickness resection (FTRD system). When OTSC-associated complications occur or re-therapy at the OTSC site is needed, OTSC removal may be indicated. An experimental study...

Cite
Bauder M, Meier B, Caca K, et al. Endoscopic removal of over-the-scope clips: Clinical experience with a bipolar cutting device. United European Gastroenterol J. 2016;5(4):479-484doi: 10.1177/2050640616671846.
Bauder, M., Meier, B., Caca, K., & Schmidt, A. (2017). Endoscopic removal of over-the-scope clips: Clinical experience with a bipolar cutting device. United European gastroenterology journal, 5(4), 479-484. https://doi.org/10.1177/2050640616671846
Bauder, Markus, et al. "Endoscopic removal of over-the-scope clips: Clinical experience with a bipolar cutting device." United European gastroenterology journal vol. 5,4 (2017): 479-484. doi: https://doi.org/10.1177/2050640616671846
Bauder M, Meier B, Caca K, Schmidt A. Endoscopic removal of over-the-scope clips: Clinical experience with a bipolar cutting device. United European Gastroenterol J. 2017 Jun;5(4):479-484. doi: 10.1177/2050640616671846. Epub 2016 Oct 06. PMID: 28588877; PMCID: PMC5446147.
Copy Download .nbib Format: NLM
Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation.

United European gastroenterology journal

Laurent L, Vullierme MP, Rebours V, Maire F, Hentic O, Francoz C, Durand F, Ruszniewski P, Lévy P.
PMID: 28588880
United European Gastroenterol J. 2017 Jun;5(4):499-503. doi: 10.1177/2050640616664842. Epub 2016 Aug 16.

BACKGROUND AND AIMS: Some studies have explored the prevalence of pancreatic cystic lesions (PCLs). Only one study based on magnetic resonance imaging (MRI) report examination focused specifically on intraductal papillary mucinous neoplasm (IPMN) in a European general population. The...

Cite
Laurent L, Vullierme MP, Rebours V, et al. Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation. United European Gastroenterol J. 2016;5(4):499-503doi: 10.1177/2050640616664842.
Laurent, L., Vullierme, M. P., Rebours, V., Maire, F., Hentic, O., Francoz, C., Durand, F., Ruszniewski, P., & Lévy, P. (2017). Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation. United European gastroenterology journal, 5(4), 499-503. https://doi.org/10.1177/2050640616664842
Laurent, Lucie, et al. "Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation." United European gastroenterology journal vol. 5,4 (2017): 499-503. doi: https://doi.org/10.1177/2050640616664842
Laurent L, Vullierme MP, Rebours V, Maire F, Hentic O, Francoz C, Durand F, Ruszniewski P, Lévy P. Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation. United European Gastroenterol J. 2017 Jun;5(4):499-503. doi: 10.1177/2050640616664842. Epub 2016 Aug 16. PMID: 28588880; PMCID: PMC5446141.
Copy Download .nbib Format: NLM
IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

United European gastroenterology journal

Ramos A, Calvet X, Sicilia B, Vergara M, Figuerola A, Motos J, Sastre A, Villoria A, Gomollón F.
PMID: 26279841
United European Gastroenterol J. 2015 Aug;3(4):335-42. doi: 10.1177/2050640615577532.

BACKGROUND AND AIMS: Data on the prevalence of work disability in patients with inflammatory bowel disease (IBD) are heterogeneous. As most studies have been performed in selected, often severe, IBD patients, the true prevalence of disability in the community...

Cite
Ramos A, Calvet X, Sicilia B, et al. IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study. United European Gastroenterol J. 2015;3(4):335-42doi: 10.1177/2050640615577532.
Ramos, A., Calvet, X., Sicilia, B., Vergara, M., Figuerola, A., Motos, J., Sastre, A., Villoria, A., & Gomollón, F. (2015). IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study. United European gastroenterology journal, 3(4), 335-42. https://doi.org/10.1177/2050640615577532
Ramos, Alexis, et al. "IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study." United European gastroenterology journal vol. 3,4 (2015): 335-42. doi: https://doi.org/10.1177/2050640615577532
Ramos A, Calvet X, Sicilia B, Vergara M, Figuerola A, Motos J, Sastre A, Villoria A, Gomollón F. IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study. United European Gastroenterol J. 2015 Aug;3(4):335-42. doi: 10.1177/2050640615577532. PMID: 26279841; PMCID: PMC4528207.
Copy Download .nbib Format: NLM
Young Talent Group introduces young guest editors for UEG Journal.

United European gastroenterology journal

[No authors listed]
PMID: 26425346
United European Gastroenterol J. 2015 Aug;3(4):403. doi: 10.1177/2050640615596323.

No abstract available.

Cite
Young Talent Group introduces young guest editors for UEG Journal. United European Gastroenterol J. 2015;3(4):403doi: 10.1177/2050640615596323.
(2015). Young Talent Group introduces young guest editors for UEG Journal. United European gastroenterology journal, 3(4), 403. https://doi.org/10.1177/2050640615596323
"Young Talent Group introduces young guest editors for UEG Journal." United European gastroenterology journal vol. 3,4 (2015): 403. doi: https://doi.org/10.1177/2050640615596323
Young Talent Group introduces young guest editors for UEG Journal. United European Gastroenterol J. 2015 Aug;3(4):403. doi: 10.1177/2050640615596323. PMID: 26425346; PMCID: PMC4528217.
Copy Download .nbib Format: NLM
What it means to receive the UEG Rising Star Award.

United European gastroenterology journal

[No authors listed]
PMID: 26425345
United European Gastroenterol J. 2015 Aug;3(4):400-2. doi: 10.1177/2050640615596322.

No abstract available.

Cite
What it means to receive the UEG Rising Star Award. United European Gastroenterol J. 2015;3(4):400-2doi: 10.1177/2050640615596322.
(2015). What it means to receive the UEG Rising Star Award. United European gastroenterology journal, 3(4), 400-2. https://doi.org/10.1177/2050640615596322
"What it means to receive the UEG Rising Star Award." United European gastroenterology journal vol. 3,4 (2015): 400-2. doi: https://doi.org/10.1177/2050640615596322
What it means to receive the UEG Rising Star Award. United European Gastroenterol J. 2015 Aug;3(4):400-2. doi: 10.1177/2050640615596322. PMID: 26425345; PMCID: PMC4528216.
Copy Download .nbib Format: NLM
Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study.

United European gastroenterology journal

de Kort S, Bouwens MW, Weijenberg MP, Janssen-Heijnen ML, de Bruïne AP, Riedl R, Masclee AA, Sanduleanu S.
PMID: 28507754
United European Gastroenterol J. 2017 Apr;5(3):415-423. doi: 10.1177/2050640616664271. Epub 2016 Aug 09.

BACKGROUND: Diabetes mellitus (DM) is associated with a greater risk for colorectal cancer (CRC).OBJECTIVE: The objective of this article is to examine the endoscopic phenotype and histopathology of colorectal polyps in patients with vs without DM.METHODS: We conducted a...

Cite
de Kort S, Bouwens MW, Weijenberg MP, et al. Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study. United European Gastroenterol J. 2016;5(3):415-423doi: 10.1177/2050640616664271.
de Kort, S., Bouwens, M. W., Weijenberg, M. P., Janssen-Heijnen, M. L., de Bruïne, A. P., Riedl, R., Masclee, A. A., & Sanduleanu, S. (2017). Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study. United European gastroenterology journal, 5(3), 415-423. https://doi.org/10.1177/2050640616664271
de Kort, Sander, et al. "Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study." United European gastroenterology journal vol. 5,3 (2017): 415-423. doi: https://doi.org/10.1177/2050640616664271
de Kort S, Bouwens MW, Weijenberg MP, Janssen-Heijnen ML, de Bruïne AP, Riedl R, Masclee AA, Sanduleanu S. Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study. United European Gastroenterol J. 2017 Apr;5(3):415-423. doi: 10.1177/2050640616664271. Epub 2016 Aug 09. PMID: 28507754; PMCID: PMC5415214.
Copy Download .nbib Format: NLM
Fecal immunochemical test-based colorectal cancer screening: The gender dilemma.

United European gastroenterology journal

Grobbee EJ, Wieten E, Hansen BE, Stoop EM, de Wijkerslooth TR, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Kuipers EJ, Spaander MC.
PMID: 28507758
United European Gastroenterol J. 2017 Apr;5(3):448-454. doi: 10.1177/2050640616659998. Epub 2016 Jul 14.

BACKGROUND: Despite differences between men and women in incidence of colorectal cancer (CRC) and its precursors, screening programs consistently use the same strategy for both genders.OBJECTIVE: The objective of this article is to illustrate the effects of gender-tailored screening,...

Cite
Grobbee EJ, Wieten E, Hansen BE, et al. Fecal immunochemical test-based colorectal cancer screening: The gender dilemma. United European Gastroenterol J. 2016;5(3):448-454doi: 10.1177/2050640616659998.
Grobbee, E. J., Wieten, E., Hansen, B. E., Stoop, E. M., de Wijkerslooth, T. R., Lansdorp-Vogelaar, I., Bossuyt, P. M., Dekker, E., Kuipers, E. J., & Spaander, M. C. (2017). Fecal immunochemical test-based colorectal cancer screening: The gender dilemma. United European gastroenterology journal, 5(3), 448-454. https://doi.org/10.1177/2050640616659998
Grobbee, Esmée J, et al. "Fecal immunochemical test-based colorectal cancer screening: The gender dilemma." United European gastroenterology journal vol. 5,3 (2017): 448-454. doi: https://doi.org/10.1177/2050640616659998
Grobbee EJ, Wieten E, Hansen BE, Stoop EM, de Wijkerslooth TR, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Kuipers EJ, Spaander MC. Fecal immunochemical test-based colorectal cancer screening: The gender dilemma. United European Gastroenterol J. 2017 Apr;5(3):448-454. doi: 10.1177/2050640616659998. Epub 2016 Jul 14. PMID: 28507758; PMCID: PMC5415207.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 893 entries